Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
Tremonton
•
September 16, 2026
•
2 views
Blood-based testing could open new markets for the Co-Dx® PCR platform, including HIV and hepatitis B and C
Source: The Leader (Tremonton) | https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



